Quality adjusted progression-free-period of Carfilzomib-dexamethasone maintenance therapy for patients with multiple myeloma treated for first relapse – findings from a Nordic Myeloma Study Group randomized phase II trial
- Kongsgaard Nielsen, L. (Speaker)
- Fredrik H. Schjesvold (Co-author)
- Möller, S. (Co-author)
- N Guldbrandsen (Co-author)
- M Hansson (Co-author)
- K Remes (Co-author)
- Valdas Peceliunas (Co-author)
- Abildgaard, N. (Co-author)
- Henrik Gregersen (Co-author)
- Madeleine King (Co-author)
Activity: Talks and presentations › Conference presentations